Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors
- PMID: 25168383
- DOI: 10.1093/hmg/ddu445
Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors
Abstract
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by the expansion of a CAG repeat in the androgen receptor (AR) gene. Mutant AR has been postulated to alter the expression of genes important for mitochondrial function and induce mitochondrial dysfunction. Here, we show that the expression levels of peroxisome proliferator-activated receptor-γ (PPARγ), a key regulator of mitochondrial biogenesis, were decreased in mouse and cellular models of SBMA. Treatment with pioglitazone (PG), an activator of PPARγ, improved the viability of the cellular model of SBMA. The oral administration of PG also improved the behavioral and histopathological phenotypes of the transgenic mice. Furthermore, immunohistochemical and biochemical analyses demonstrated that the administration of PG suppressed oxidative stress, nuclear factor-κB (NFκB) signal activation and inflammation both in the spinal cords and skeletal muscles of the SBMA mice. These findings suggest that PG is a promising candidate for the treatment of SBMA.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.Nat Med. 2003 Jun;9(6):768-73. doi: 10.1038/nm878. Epub 2003 May 18. Nat Med. 2003. PMID: 12754502
-
Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).Prog Neurobiol. 2012 Dec;99(3):246-56. doi: 10.1016/j.pneurobio.2012.05.007. Epub 2012 May 15. Prog Neurobiol. 2012. PMID: 22609045 Review.
-
[Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].Rinsho Shinkeigaku. 2000 Dec;40(12):1193-5. Rinsho Shinkeigaku. 2000. PMID: 11464455 Japanese.
-
Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice.Hum Mol Genet. 2001 Jan 15;10(2):107-16. doi: 10.1093/hmg/10.2.107. Hum Mol Genet. 2001. PMID: 11152658
-
Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor.Neurotox Res. 2005;7(3):219-30. doi: 10.1007/BF03036451. Neurotox Res. 2005. PMID: 15897156 Review.
Cited by
-
Label-free morphological sub-population cytometry for sensitive phenotypic screening of heterogenous neural disease model cells.Sci Rep. 2022 Jun 16;12(1):9296. doi: 10.1038/s41598-022-12250-0. Sci Rep. 2022. PMID: 35710681 Free PMC article.
-
Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy.Sci Rep. 2019 Mar 5;9(1):3539. doi: 10.1038/s41598-019-40118-3. Sci Rep. 2019. PMID: 30837566 Free PMC article.
-
Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.Am J Neurodegener Dis. 2016 Jun 1;5(2):102-30. eCollection 2016. Am J Neurodegener Dis. 2016. PMID: 27335702 Free PMC article. Review.
-
Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy.Front Endocrinol (Lausanne). 2019 Aug 20;10:569. doi: 10.3389/fendo.2019.00569. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31481932 Free PMC article.
-
Diabetes pharmacotherapy and effects on the musculoskeletal system.Diabetes Metab Res Rev. 2019 Feb;35(2):e3100. doi: 10.1002/dmrr.3100. Epub 2018 Dec 20. Diabetes Metab Res Rev. 2019. PMID: 30467957 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
